XML 43 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans $ 43.5 $ 37.6 $ 101.5 $ 97.1
Stock-based compensation expense related to stock options, SAR and ESPP grants $ 20.9 $ 18.8 $ 42.9 $ 45.0
Common Shares Available for Grant 17,100,000   17,100,000  
Unrecognized compensation expense $ 110.3   $ 110.3  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 8 months 12 days  
Stock Options and SARs [Member]        
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 23.94 $ 25.77
Expected Volatility (in hundredths)     28.28% 31.52%
Risk-Free Interest Rate (in hundredths)     1.52% 0.78%
Dividend Yield (in hundredths)     0.75% 0.76%
Expected Life (in years)     5 years 1 month 6 days 5 years 4 months 24 days
Stock Options and SARs Rollforward [Abstract]        
Outstanding at January 1 (in shares)     9,850,000 10,744,000
Granted (in shares)     2,260,000 1,821,000
Exercised (1) (in shares) [1]     (1,674,000) (1,673,000)
Forfeited (in shares)     (269,000) (241,000)
Outstanding at September 30 (2) (in shares) [2] 10,167,000 10,651,000 10,167,000 10,651,000
Stock Options and SARs Vested or Expected to Vest (in shares) [3] 9,799,000 10,300,000 9,799,000 10,300,000
Stock Options and SARs Exercisable at September 30 (in shares) [4] 5,517,000 6,302,000 5,517,000 6,302,000
Intrinsic Value of Stock Options/SARs Exercised     $ 66.6 $ 58.7
Intrinsic Value of Stock Options/SARs Outstanding $ 147.8 $ 240.8 $ 147.8 $ 240.8
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding     4 years 3 months 18 days 4 years 1 month 6 days
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest 145.9 237.2 $ 145.9 $ 237.2
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years)al Term     4 years 3 months 18 days 4 years
Aggregate Intrinsic Value for Exercisable Units $ 123.2 $ 196.3 $ 123.2 $ 196.3
Weighted average remaining contractual life for exercisable options/SARs (in years)     2 years 9 months 18 days 2 years 9 months 18 days
Weighted Average Grant Price Stock Option and SARs [Rollforward]        
Outstanding at January 1 (price per share)     $ 75.53 $ 67.98
Granted (price per share)     96.24 94.87
Exercised (1) (price per share) [1]     55.63 49.85
Forfeited (price per share)     90.22 85.77
Outstanding at September 30 (2) (price per share) [2] $ 83.02 $ 75.02 83.02 75.02
Vested or Expected to Vest (3) (price per share) [3] 82.69 74.60 82.69 74.60
Exercisable at September 30 (4) (price per share) [4] $ 75.59 $ 66.46 75.59 66.46
ESPP [Member]        
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 22.10 $ 19.28
Expected Volatility (in hundredths)     26.96% 36.54%
Risk-Free Interest Rate (in hundredths)     0.89% 0.43%
Dividend Yield (in hundredths)     0.71% 0.82%
Expected Life (in years)     6 months 6 months
Restricted Stock And Restricted Stock Units [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Unrecognized compensation expense $ 191.2   $ 191.2  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 7 months 6 days  
Restricted Stock/Restricted Stock Units [Roll Forward]        
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost $ 15.8 $ 13.1 $ 50.0 $ 45.5
Outstanding at January 1 (in shares)     3,962,000 4,908,000
Granted (in shares)     1,061,000 833,000
Released (1) (in shares) [5]     (837,000) (1,392,000)
Forfeited (in shares)     (190,000) (269,000)
Outstanding at September 30 (2) (in shares) [6] 3,996,000 4,080,000 3,996,000 4,080,000
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward]        
Outstanding at January 1 (price per share)     $ 79.63 $ 70.35
Granted (price per share)     97.26 87.76
Released (1) (price per share) [5]     59.67 53.15
Forfeited (price per share)     84.66 76.40
Outstanding at September 30 (2) (price per share) [6] $ 88.25 $ 79.37 $ 88.25 $ 79.37
Performance Units and Performance Stock Disclosures [Abstract]        
Intrinsic value released during the year     $ 81.6 $ 116.3
Aggregate intrinsic value of stock and units outstanding $ 386.6 $ 394.6 386.6 394.6
Performance Units and Performance Stock [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans 6.8 5.7 8.6 $ 6.6
Unrecognized compensation expense $ 9.4   $ 9.4  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 3 months 18 days  
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 113.81 $ 112.09
Expected Volatility (in hundredths)     32.19% 32.01%
Risk-Free Interest Rate (in hundredths)     1.60% 0.89%
Restricted Stock/Restricted Stock Units [Roll Forward]        
Outstanding at January 1 (in shares)     545,290  
Granted (in shares)     78,527  
Released (1) (in shares) [5]     240,320  
Outstanding at September 30 (2) (in shares) 502,331   502,331  
Performance Units and Performance Stock Disclosures [Abstract]        
Performance Period for Performance Units and Shares     3 years  
Additional Performance Awards Granted     118,834  
Minimum Performance Multiple at the Completion of the Performance Period     0.00%  
Maximum Performance Multiple at the Completion of the Performance Period     200.00%  
Maximum Performance Units and Stock Allowed to be Outstanding     856,218  
Minimum Performance Units and Stock Allowed to be Outstanding     148,444  
Intrinsic value released during the year     $ 23.6  
Aggregate intrinsic value of stock and units outstanding $ 48.6   $ 48.6  
Term Of Zero- Coupon Risk- Free Interest Rate In Years Derived From Treasury Constant Maturities Yield Curve     3 years 3 months 7 days  
Lease And Well [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans 9.5 8.9 $ 30.0 $ 28.2
Gathering And Processing Costs [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans 0.1 0.4 0.5 1.0
Exploration Costs [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans 4.7 4.1 16.1 15.6
General And Administrative [Member]        
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Compensation expense related to the company's stock-based compensation plans $ 29.2 $ 24.2 $ 54.9 $ 52.3
[1] The total intrinsic value of stock options/SARs exercised for the nine months ended September 30, 2017 and 2016 was $66.6 million and $58.7 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs.
[2] The total intrinsic value of stock options/SARs outstanding at September 30, 2017 and 2016 was $147.8 million and $240.8 million, respectively. At September 30, 2017 and 2016, the weighted average remaining contractual life was 4.3 years and 4.1 years, respectively.
[3] The total intrinsic value of stock options/SARs vested or expected to vest at September 30, 2017 and 2016 was $145.9 million and $237.2 million, respectively. At September 30, 2017 and 2016, the weighted average remaining contractual life was 4.3 years and 4.0 years, respectively.
[4] The total intrinsic value of stock options/SARs exercisable at September 30, 2017 and 2016 was $123.2 million and $196.3 million, respectively. At September 30, 2017 and 2016, the weighted average remaining contractual life was 2.8 years and 2.8 years, respectively.
[5] The total intrinsic value of restricted stock and restricted stock units released for the nine months ended September 30, 2017 and 2016 was $81.6 million and $116.3 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
[6] The total intrinsic value of restricted stock and restricted stock units outstanding at September 30, 2017 and 2016 was $386.6 million and $394.6 million, respectively.